Greg Skalicky

Greg Skalicky is currently the Chief Revenue Officer & President at EVERSANA. Greg has over 20 years of experience in the industry, having served in various leadership roles at both Syneos Health and inVentiv Health.

Skalicky began their career at inVentiv Health Clinical in 1997, where they quickly rose through the ranks to become the Chief Enterprise Business Officer. In this role, they were responsible for operational performance and P&L oversight across Business Development, Late Phase Research, and Enterprise Relationships.

In 2018, Skalicky left inVentiv Health to join Syneos Health as their Executive Vice President & General Manager. Greg held this position until August 2018, when they joined EVERSANA.

At EVERSANA, Skalicky is responsible for leading the company's global commercialization efforts and driving revenue growth. Greg is a proven leader with a track record of success in the industry, and under their guidance, EVERSANA is poised for continued success in the years to come.

Greg Skalicky has a Master of Business Administration from the Villanova School of Business and a Bachelor of Science in Biology from Temple University. Greg also has a degree in Biology from Penn State University.

They work with Jim Burke - General Manager, Revenue Management, Krista Pinto - President, Deployment Solutions, and Kelly Baker - CFO. Their manager is Jim Lang, CEO.